Stock Events

Stock Events

Teva- Pharmaceutical Industries 

$36.35
652
-$0.50-1.36% Thursday 20:00
+$0.19+0.52%Thursday 23:30After hours

Statistics

Day High
36.74
Day Low
36.04
52W High
38.37
52W Low
18.21
Volume
4,014,108
Avg. Volume
5,513,387
Mkt Cap
42.36B
P/E Ratio
24.59
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 17
$0.09
Sep 17
$0.09
Jun 17
$0.34
Mar 17
$0.34
Dec 16
$0.34
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

11NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.02
0.32
0.63
0.93
Expected EPS
0.69705496644
Actual EPS
N/A

Financials

8.17%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
17.26BRevenue
1.41BNet Income

Analyst Ratings

43.71Average Price Target
The highest estimate is 48.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TEVA. It's not an investment recommendation.
NVIDIA
122
NVDA
Amazon
118
AMZN
Microsoft
116
MSFT
Apple
115
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap304.1B
Novartis, through its Sandoz division, is a leading competitor in the generic pharmaceuticals market, directly challenging Teva's product lineup.
Pfizer
PFE
Mkt Cap162.16B
Pfizer, with its Upjohn division now merged into Viatris, competes in both the generic and branded pharmaceutical markets, overlapping with Teva's business areas.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie competes with Teva in the specialty pharmaceutical sector, particularly in areas like biosimilars and branded pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the branded pharmaceutical market, particularly in areas where Teva also operates.
Merck
MRK
Mkt Cap370.89B
Merck competes with Teva in the development and marketing of branded pharmaceuticals, especially in therapeutic areas where Teva is active.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences competes with Teva in the specialty pharmaceuticals market, particularly in the antiviral sector where Teva also has a presence.
AMGEN
AMGN
Mkt Cap236.38B
Amgen competes with Teva in the biopharmaceutical sector, particularly in the development of biosimilars, a growing area of Teva's business.
Sanofi
SNY
Mkt Cap106.01B
Sanofi competes with Teva in both the branded and generic pharmaceutical markets, with a broad product portfolio that overlaps with Teva's.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes with Teva in the branded pharmaceutical sector, particularly in areas like respiratory and cardiovascular diseases where Teva is also active.

About

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Show more...
CEO
Richard D. Francis
Employees
32842
Country
Israel
ISIN
US8816242098
WKN
000883035

Listings

MX
MX
TEVAN.MX
STU
DE
TEV.STU
XNYS
US
TEVA
SA
BR
T1EV34.SA

0 Comments

Share your thoughts

FAQ

What is Teva- Pharmaceutical Industries stock price today?▼
The current price of TEVA is $36.35 USD — it has decreased by -1.36% in the past 24 hours. Watch Teva- Pharmaceutical Industries stock price performance more closely on the chart.
What is Teva- Pharmaceutical Industries stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Teva- Pharmaceutical Industries stocks are traded under the ticker TEVA.
Is Teva- Pharmaceutical Industries stock price growing?▼
TEVA stock has fallen by -0.03% compared to the previous week, the month change is a -0.36% fall, over the last year Teva- Pharmaceutical Industries has showed a +82.76% increase.
What is Teva- Pharmaceutical Industries market cap?▼
Today Teva- Pharmaceutical Industries has the market capitalization of 42.36B
When is the next Teva- Pharmaceutical Industries earnings date?▼
Teva- Pharmaceutical Industries is going to release the next earnings report on November 11, 2026.
What were Teva- Pharmaceutical Industries earnings last quarter?▼
TEVA earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.05 USD resulting in a -60.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Teva- Pharmaceutical Industries revenue for the last year?▼
Teva- Pharmaceutical Industries revenue for the last year amounts to 17.26B USD.
What is Teva- Pharmaceutical Industries net income for the last year?▼
TEVA net income for the last year is 1.41B USD.
Does Teva- Pharmaceutical Industries pay dividends?▼
Yes, TEVA dividends are paid quarterly. The last dividend per share was 0.09 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Teva- Pharmaceutical Industries have?▼
As of September 11, 2026, the company has 32,842 employees.
In which sector is Teva- Pharmaceutical Industries located?▼
Teva- Pharmaceutical Industries operates in the Health & Wellness sector.
When did Teva- Pharmaceutical Industries complete a stock split?▼
The last stock split for Teva- Pharmaceutical Industries was on July 01, 2004 with a ratio of 2:1.
Where is Teva- Pharmaceutical Industries headquartered?▼
Teva- Pharmaceutical Industries is headquartered in TEL AVIV, Israel.